Robert Luxenhofer

Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

Matthias Barz, Robert Luxenhofer, Rudolf Zentel et al. · Polymer Chemistry · 2011 · 416 citations · Full text

Natural Sciences, Materials Science, Molecular Pharmaceutics +16

On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s

Juliane Ulbricht, Rainer Jordan, Robert Luxenhofer · Biomaterials · 2014 · 331 citations

Natural Sciences, Chemical Engineering, Biocompatibility +11

Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors

Assaf Zinger, Lilach Koren, Omer Adir et al. · ACS Nano · 2019 · 318 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs

Robert Luxenhofer, Anita Schulz, Caroline Roques et al. · Biomaterials · 2010 · 283 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s

Florian Gaertner, Robert Luxenhofer, Birgit Blechert et al. · Journal of Controlled Release · 2007 · 253 citations

Natural Sciences, Pharmacokinetics, Pharmacology +3